CRIS Current Research Information System

LODATO, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.781
NA - Nord America 3.198
EU - Europa 2.120
AF - Africa 198
SA - Sud America 114
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.416
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.157
VN - Vietnam 1.921
SG - Singapore 717
CN - Cina 596
GB - Regno Unito 559
SE - Svezia 295
DE - Germania 258
IT - Italia 254
HK - Hong Kong 162
FR - Francia 139
IN - India 129
UA - Ucraina 116
RU - Federazione Russa 114
IE - Irlanda 85
BR - Brasile 80
NL - Olanda 70
CI - Costa d'Avorio 61
CH - Svizzera 54
JP - Giappone 52
ZA - Sudafrica 50
KR - Corea 44
EE - Estonia 43
TG - Togo 39
BD - Bangladesh 33
FI - Finlandia 33
CA - Canada 28
JO - Giordania 27
PL - Polonia 20
TH - Thailandia 20
BG - Bulgaria 19
NG - Nigeria 18
PH - Filippine 18
BE - Belgio 17
SC - Seychelles 16
GR - Grecia 15
AR - Argentina 13
IR - Iran 10
ES - Italia 9
TR - Turchia 9
SA - Arabia Saudita 8
TW - Taiwan 8
IQ - Iraq 7
EC - Ecuador 6
MX - Messico 6
LT - Lituania 5
PK - Pakistan 5
CO - Colombia 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
AU - Australia 3
CL - Cile 3
ID - Indonesia 3
PE - Perù 3
AO - Angola 2
CR - Costa Rica 2
DK - Danimarca 2
HR - Croazia 2
KE - Kenya 2
LB - Libano 2
MA - Marocco 2
MY - Malesia 2
NI - Nicaragua 2
NO - Norvegia 2
PY - Paraguay 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BO - Bolivia 1
DM - Dominica 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
GN - Guinea 1
IL - Israele 1
MT - Malta 1
NP - Nepal 1
RO - Romania 1
TL - Timor Orientale 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
VG - Isole Vergini Britanniche 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.416
Salva come PNG Salva come JPEG
Città #
Singapore 515
Southend 487
Ho Chi Minh City 446
Hanoi 396
Ashburn 361
Chandler 339
Fairfield 285
Dong Ket 242
San Jose 158
Hong Kong 149
Santa Clara 139
Houston 129
Wilmington 110
Woodbridge 103
Seattle 100
Ann Arbor 99
Princeton 93
Dublin 84
Boardman 78
Hefei 76
Beijing 73
Cambridge 73
Jacksonville 68
Da Nang 66
Abidjan 61
Haiphong 58
Westminster 48
Bern 47
Lauterbourg 45
Tokyo 43
Los Angeles 42
Nanjing 42
Lomé 39
Council Bluffs 35
Thái Nguyên 34
Padova 33
Dallas 32
Medford 32
New York 32
Saint Petersburg 32
Ha Long 31
Seoul 31
Biên Hòa 29
Munich 28
Amman 27
Buffalo 27
Quận Bình Thạnh 26
Berlin 25
Dearborn 25
Hải Dương 25
Milan 25
Helsinki 23
Bologna 22
Can Tho 22
Bắc Ninh 20
Abeokuta 18
Vũng Tàu 18
Brussels 17
Ninh Bình 17
Shenyang 17
Sofia 17
São Paulo 17
Vinh 17
Bremen 16
Hebei 16
Jinan 16
Nanchang 16
Changsha 15
Florence 15
Guangzhou 15
Turin 14
Bắc Giang 13
Frankfurt am Main 13
London 12
Chicago 11
Falkenstein 11
Quận Phú Nhuận 11
Shanghai 11
Zhengzhou 11
Falls Church 10
Jiaxing 10
Orem 10
Redondo Beach 10
Tianjin 10
Torino 10
Toronto 10
Mülheim 9
Norwalk 9
San Diego 9
The Dalles 9
Turku 9
Uyen Hung 9
Xi'an 9
Hangzhou 8
Lấp Vò 8
Mahé 8
Nam Định 8
Pune 8
Rome 8
Augusta 7
Totale 6.252
Salva come PNG Salva come JPEG
Nome #
G-CSF in Peg-IFN induced neutropenia in liver transplanted patients with HCV recurrence 614
G-CSF administration is not related to PEG-IFN alfa-213 treatment duration nor response in liver transplanted patients with HCV recurrence 518
Outcomes and survival after TIPS positioning: a single center experience 407
Two cases of severe autoimmune manifestations following virological response to peginterferon alpha- 2b + ribavirin in liver transplanted patients with recurrence of chronic hepatitis C 339
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 328
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis 278
Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy 262
Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid. 257
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY 237
Correlazione materno-fetale degli acidi biliari in corso di colestasi gravidica 221
Adverse effects of proton pump inhibitors. 219
Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study 218
Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases. 216
Reliability of imaging techniques in assessing portal venous thrombosis in patients with hepatocellular carcinoma candidates for liver transplantation 214
Affidabilità della combinazione di angioecografia perfusionale ed altre tecniche di imaging nella valutazione della trombosi portale in pazienti con epatocarcinoma (HCC) candidati al trapianto di fegato 213
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 212
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 207
Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis. 200
Thorough assessment of portal venous thrombosis in patients with HCC allows adequate selection of candidates for liver transplantation 197
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. 182
Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: An emerging fungal agent. 180
HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE 179
High incidence of allograft dysfunction in liver transplant patients treated with PEG-Interferon alfa-2b and Ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis? 178
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 176
Pharmacological modulation of MRP2 in primary biliary cirrhosis 173
Regolazione dei trasportatori placentari degli acidi biliari MRP2, MRP3, MRP4 da parte dell’acido ursodesossicolico in corso di colestasi gravidica 164
Proton pump inhibitors in cirrhosis: tradition or evidence based practice? 164
Superior efficacy of twice a week administration of peginterferon alpha-2b plus ribavirin in obtaining SVR in HCV genotype 1 163
CMV infection and biliary tract complications are related with a poor outcome of liver transplantation for HCV-related cirrhosis 163
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 163
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis. 159
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis 158
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 157
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 156
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. 156
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 155
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 155
MRP2 is upregulated by UDCA in cholestasis of pregnancy. 152
Placental MRP2 is upregulated by UDCA in cholestasis of pregnancy. 138
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis. 138
UDCA UP-REGULATES HUMAN PLACENTAL OATP-A EXPRESSION IN INTRAHEPATIC CHOLESTASIS OF PREGNANCY 136
Modulation of placental bilirubin and bile acids transporters during cholestasis of pregnancy. 124
Effect of combined IFN-Alpha/Ribavirin Treatment in HCV disease-related progression 120
Outcomes and survival after TIPS positioning: a single center experience 120
Prospective evaluation of aberrant p16 methylation in serum of patients before and after therapy for localized HCC. 102
Systemic lupus erythematosus following virological response to peginterferon alfa-2b in a transplanted patient with chronic hepatitis C recurrence 101
Impact of multidisciplinary discussion on pancreatic neuroendocrine tumours, experience of a tertiary centre 43
THE GASTROPACK SYSTEM, A NOVEL METHOD TO ACCESS TO GASTROENTEROLOGICAL CARE: RESULTS OF THE UPPER GASTROINTESTINAL SYMPTOM POPULATION 34
Totale 9.546
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.806
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.806
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021343 0 0 0 0 0 0 0 0 0 0 0 343
2021/20221.072 125 49 63 63 76 71 18 48 35 52 283 189
2022/20231.187 122 185 63 155 71 97 31 63 191 30 86 93
2023/2024264 13 45 13 34 19 59 9 13 28 13 9 9
2024/20251.035 45 185 80 56 175 49 47 29 27 85 36 221
2025/20263.587 1.274 225 186 145 327 169 235 52 546 224 99 105
Totale 9.546